Target intelligence / Profile preview

Leucine-rich repeat-containing protein 47 (LRRC47)

Target
LRRC47
Molecular classification
Leucine-rich repeat-containing protein, Predicted enzyme (putative phenylalanine-tRNA ligase activity), Other
01

Overview

Leucine-rich repeat-containing protein 47 (LRRC47) is a protein encoded by the LRRC47 gene in humans. It features multiple leucine-rich repeats, which are typically involved in protein-protein interactions. Experimental data indicate that LRRC47 has RNA binding capacity and is predicted to participate in phenylalanyl-tRNA aminoacylation, suggesting a possible link to translation machinery[1][3][4]. Phosphoproteomic analyses show that LRRC47 is dynamically phosphorylated in response to vasopressin in kidney collecting duct cells, implying involvement in rapid signal transduction regulating water balance, possibly through the aquaporin pathway[1]. Additionally, network studies have linked LRRC47 to oncogenic signaling modules in hepatocellular carcinoma. However, no direct evidence identifies LRRC47 as a receptor, druggable enzyme, or transporter, and there are no known approved therapeutic drugs targeting it[1][3]. While implicated in cellular signaling and possibly cancer biology, its precise molecular function and implication as a therapeutic target require further elucidation.

Other names
KIAA1185RP1-286D6.3LRRC47
02

Biological functions

RNA bindingPossible involvement in phenylalanyl-tRNA aminoacylationMay be involved in signal transduction (renal vasopressin response)Possible role in oncogenic pathways (cancer cell signaling)
03

Disease associations

Cancer (role suggested in hepatocellular carcinoma protein networks)Other

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 47 (LRRC47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 47 (LRRC47).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call